ITI Pharma and Healthcare Fund Regular vs Tata India Pharma & Healthcare Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹208 Cr | ₹1208 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 08 Nov 2021 | 28 Dec 2015 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | Nifty Pharma TRI |
| Turn Over | % | 26.49% |
| Expense Ratio | 2.35 | 2.14 |
| Manager | Rohan Korde | Meeta Shetty |
| ISIN Code | INF00XX01BL5 | INF277K016A9 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Month | 3.47% | 4.66% |
| 6 Month | 20.7% | 16.53% |
| 1 Year | 43.48% | 41.34% |
| 3 Year | 20.61% | 22.4% |
| 5 Year | - | 27.33% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 37.03% | 31.82% |
| 3 Year | 32% | 32.32% |
| 5 Year | - | 25.8% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Year | 20.74% | 6.67% |
| 3 Year | 19.19% | 17.46% |
| 5 Year | - | 14.22% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Standard Deviation | 14.52% | 14.23% |
| Sharp | - | 0.74% |
| Beta | - | 0.9% |
| Alpha | - | 2.85% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Name | Rohan Korde | Meeta Shetty |
| Total AUM | ₹4626 Cr | ₹17847 Cr |
| Fund Manage | 10 | 5 |
| ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 1.8 | 5.39 |
| Large Cap | 38.11 | 40.33 |
| Mid Cap | 26.43 | 30.82 |
| Small Cap | 33.66 | 23.46 |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 1.8 | 5.39 |
| Pharmaceuticals & Biotechnology | 77 | 76.28 |
| Healthcare Services | 18.01 | 14.31 |
| Chemicals & Petrochemicals | 0.96 | 0.39 |
| Fertilizers & Agrochemicals | 1.03 | 0.83 |
| Insurance | 1.2 | 2.14 |
| Retailing | - | 0.66 |
Top Comparisons
Nippon India Growth Fund-Growth Plan-Growth Option
3Y Returns26.16%
PGIM India Midcap Opportunities Fund - Regular Plan - Growth Option
3Y Returns14.08%
Mahindra Manulife Large Cap Fund - Regular Plan - Growth
3Y Returns12.51%
BANDHAN Large Cap Fund - Regular Plan - Growth
3Y Returns14.17%
Aditya Birla Sun Life Medium Term Plan - Growth - Regular Plan
3Y Returns13.65%
Axis Strategic Bond Fund - Regular Plan - Growth Option
3Y Returns6.46%
Invesco India - Invesco Global Equity Income Fund of Fund - Regular Plan - Growth
3Y Returns11.18%
Invesco India - Invesco Pan European Equity Fund of Fund - Regular Plan - Growth Option
3Y Returns4.28%